Just do something. Of course, every discussion about treating patients with obesity must include a discussion about the breakthroughs providers and patients are seeing through the use of what MacLeod calls novel medications. Idzik mentions incretin-based therapies, because I think the GLP-1s really have revolutionized obesity care. She says that when I frame GLP-1s for patients, I say to them, The medicine really increases your odds that all of your efforts are actually going to turn into measurable losses. Alongside lifestyle changes in diet and exercise, starting on a GLP-1 just helps them put that action into work
Look specifically for: Wegovy, Zepbound, Ozempic, Mounjaro, phentermine, and metformin Notes on prior authorization, step therapy, or exclusions Whether coverage is limited to certain diagnoses (e.g., diabetes only) If youre unsure where to find this information, your insurance provider or HR representative can help
doi:10.3748/wjg.v17.i1.105 [65] Modi RM, Hinton A, Pinkhas D, et al
Pricing as of June 2026: $199/mo semaglutide initial
Conclusion Heres the bottom line: Retatrutide offers exceptional weight loss potential , possibly the most powerful weve seen so far